According to the Zhitong Finance App, Hokuriku Pharmaceutical (300016.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 1,059 billion yuan, an increase of 21.30% over the previous year. Net profit attributable to shareholders of listed companies was 114 million yuan, an increase of 157.83% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 101 million yuan, an increase of 200.55% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.